Sort by
Keyphrases
Positron Emission Tomography
100%
Early Prediction
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Lymphoma
100%
Targeted Therapy
100%
Fluorothymidine
100%
NPM-ALK
100%
ALK-positive
100%
Everolimus
66%
NVP-AUY922
50%
Xenotransplant
33%
Immunostaining
16%
Fluorodeoxyglucose
16%
Therapeutic Effect
16%
18F-fluorodeoxyglucose (18F-FDG)
16%
Response Prediction
16%
Response Predictors
16%
Ki-67
16%
Early Treatment
16%
Imaging Studies
16%
Heat Shock Protein 90 (Hsp90)
16%
Signal Transduction
16%
Targeted Treatment
16%
Lymphoma Cells
16%
Fluorodeoxyglucose Uptake
16%
Immunodeficient Mice
16%
Response to Treatment
16%
Specific Inhibitor
16%
MTOR Inhibitor
16%
Biochemical Analysis
16%
MTT Assay
16%
Oncogenic Signaling
16%
As(V)
16%
Treatment Course
16%
Anaplastic Large Cell Lymphoma
16%
Cleaved caspase-3
16%
Resistance Prediction
16%
18F-fluorothymidine
16%
ALK-positive Large B-cell Lymphoma
16%
Aggressive Lymphoma
16%
Relapsed or Refractory
16%
Clinical Outcome Prediction
16%
Medicine and Dentistry
Positron Emission Tomography
100%
Fluorodeoxyglucose
100%
Targeted Therapy
100%
Everolimus
80%
Luminespib
60%
In Vitro
40%
Xenograft
40%
Xeno-transplant
40%
Immunohistochemistry
20%
Combination Therapy
20%
Carcinogenesis
20%
Fluorodeoxyglucose F 18
20%
Fluorine-18
20%
Treatment Response
20%
Therapy Effect
20%
Mammalian Target of Rapamycin Inhibitor
20%
Anaplastic Large Cell Lymphoma
20%
MTT Assay
20%
Anaplastic Large Cell Lymphoma Cell Line
20%
Aggressive Lymphoma
20%
Signal Transduction
20%
Cell Line
20%
Caspase 3
20%
Biochemical Analysis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorodeoxyglucose
100%
Everolimus
100%
Luminespib
75%
Anaplastic Large Cell Lymphoma
50%
Therapeutic Effect
25%
Fluorodeoxyglucose F 18
25%
Fluorine 18
25%
Mammalian Target of Rapamycin Inhibitor
25%
Carcinogenesis
25%
Combination Therapy
25%
Caspase 3
25%
Neuroscience
Positron Emission Tomography
100%
Everolimus
80%
Cell Line
40%
In Vitro
40%
Fluorine-18
40%
In Vivo
20%
Staining Technique
20%
Caspase 3
20%
Immunohistochemistry
20%
Carcinogenesis
20%
MTT Assay
20%
Signal Transduction
20%